EmailHospital Circular 05/2006
Date Issued: 6 April 2006
Distribution: Public Hospitals
Subject: Highly Specialised Drugs Program
Purpose: To advise hospitals of further changes to the Highly Specialised Drugs Program, effective 1 April 2006.
We have had recent advice from the Commonwealth Government of further changes to the Highly Specialised Drugs Program, effective 1 April 2006.
PRICE INCREASE
Apomorphine hydrochloride |
|||||
| 6104G | Injection 10 mg in 1 mL | 5 | $33.47 | Apomine | MX |
PRICE DECREASE
Cyclosporin |
|||||
| 6352H | Capsule 25 mg | 30 | $32.52 | Cicloral | HX |
| Cysporin | MX | ||||
| Neoral 25 | NV | ||||
| 6353J | Capsule 50 mg | 30 | $68.43 | Cicloral | HX |
| Cysporin | MX | ||||
| Neoral 50 | NV | ||||
| 6354K | Capsule 100 mg | 30 | $140.30 | Cicloral | HX |
| Cysporin | MX | ||||
| Neoral 100 | NV | ||||
Changes notified by hospital circular will be updated in the Guidelines on the Commonwealth/State Highly Specialised Drugs Program Guidelines website and the claim form amended.
Anna Burgess
Acting Director, Programs
Metropolitan Health & Aged Care Services
